RecruitingNot Applicable

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

United States300 participantsStarted 2018-12-20

Plain-language summary

To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.
✓. Age ≥ 18 years
✓. Plan to obtain the majority of treatment at MDACC including surgery and radiotherapy
✓. Ability to understand and willingness to sign written informed consent

✕. History of the previous solid or liquid malignancies, apart from skin cancers treated with local therapy.
✕. Existing neurocognitive impairment that is not the result of sinonasal and nasopharyngeal cancers or is treatment.
✕. Previous treatment for sinonasal or nasopharyngeal carcinomas, apart from biopsy.

MD Anderson Symptom Inventory Head and Neck Module (MDASI-HN)

Timeframe: through study completion; an average of 1 year

NCT IDNCT05733091

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2029-12-31

Shirley Su, MBBS